Profound Other Assets from 2010 to 2026

PROF Stock  USD 6.32  0.50  7.33%   
Profound Medical's Other Assets are increasing over the last several years with stable swings. Other Assets are estimated to finish at -10.92 this year. During the period from 2010 to 2026 Profound Medical Corp Other Assets regressed destribution of quarterly values had coefficient of variationof  252.08 and r-value of  0.24. View All Fundamentals
 
Other Assets  
First Reported
2015-03-31
Previous Quarter
-7.1 K
Current Value
(10.00)
Quarterly Volatility
1.1 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Profound Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Profound Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 1.1 M, Interest Expense of 737.9 K or Selling General Administrative of 27.9 M, as well as many indicators such as Price To Sales Ratio of 29.06, Dividend Yield of 0.0 or PTB Ratio of 3.89. Profound financial statements analysis is a perfect complement when working with Profound Medical Valuation or Volatility modules.
  
Build AI portfolio with Profound Stock
Check out the analysis of Profound Medical Correlation against competitors.
The Other Assets trend for Profound Medical Corp offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Profound Medical is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Profound Medical's Other Assets Growth Pattern

Below is the plot of the Other Assets of Profound Medical Corp over the last few years. It is Profound Medical's Other Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Profound Medical's overall financial position and show how it may be relating to other accounts over time.
Other Assets10 Years Trend
Pretty Stable
   Other Assets   
       Timeline  

Profound Other Assets Regression Statistics

Arithmetic Mean577,556
Geometric Mean0.00
Coefficient Of Variation252.08
Mean Deviation1,074,510
Median0.00
Standard Deviation1,455,901
Sample Variance2.1T
Range3.8M
R-Value0.24
Mean Square Error2.1T
R-Squared0.06
Significance0.35
Slope69,200
Total Sum of Squares33.9T

Profound Other Assets History

2026 -10.92
2025 -11.5
2024 -10.0
202210.3 K
20193.6 M
2017 1.0

About Profound Medical Financial Statements

Profound Medical stakeholders use historical fundamental indicators, such as Profound Medical's Other Assets, to determine how well the company is positioned to perform in the future. Although Profound Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Profound Medical's assets and liabilities are reflected in the revenues and expenses on Profound Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Profound Medical Corp. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Other Assets(11.50)(10.92)

Currently Active Assets on Macroaxis

When determining whether Profound Medical Corp is a strong investment it is important to analyze Profound Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Profound Medical's future performance. For an informed investment choice regarding Profound Stock, refer to the following important reports:
Check out the analysis of Profound Medical Correlation against competitors.
You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
Can Health Care Equipment & Supplies industry sustain growth momentum? Does Profound have expansion opportunities? Factors like these will boost the valuation of Profound Medical. Anticipated expansion of Profound directly elevates investor willingness to pay premium valuations. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Profound Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(1.22)
Revenue Per Share
0.492
Quarterly Revenue Growth
0.868
Return On Assets
(0.62)
Return On Equity
(1.24)
Investors evaluate Profound Medical Corp using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Profound Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Profound Medical's market price to deviate significantly from intrinsic value.
It's important to distinguish between Profound Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Profound Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Profound Medical's market price signifies the transaction level at which participants voluntarily complete trades.